Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
7,611,611
-
Shares change
-
+1,690,517
-
Total reported value, excl. options
-
$129,473,472
-
Value change
-
+$29,973,472
-
Put/Call ratio
-
88.57%
-
Number of buys
-
48
-
Number of sells
-
-33
-
Price
-
$17.01
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2023
102 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2023.
AVITA Medical, Inc. - Common Stock (RCEL) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,611,611 shares
of 26,475,256 outstanding shares and own 28.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,670,564 shares), VANGUARD GROUP INC (1,349,634 shares), GEODE CAPITAL MANAGEMENT, LLC (475,157 shares), STATE STREET CORP (452,229 shares), PURA VIDA INVESTMENTS, LLC (426,321 shares), MILLENNIUM MANAGEMENT LLC (274,097 shares), NORTHERN TRUST CORP (217,904 shares), Russell Investments Group, Ltd. (215,518 shares), Invesco Ltd. (177,027 shares), and EAM Investors, LLC (173,756 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.